Type 1 diabetes in youth

Handout on type 1 diabetes in youth for medical students or residents, created by the PES resident/medical student education subcommittee

Type 2 diabetes in youth

Handout on type 2 diabetes in youth for medical students or residents, created by the PES resident/medical student education subcommittee

Child with Suspected Hyperglycemia

Primary Care provider guidelines for referral.

ADA Standards of Medical Care in Diabetes – 2020

Annually revised Standards of Diabetes Care published by ADA in Diabetes Care.

Cystic Fibrosis-Related Diabetes (CFRD) ISPAD Clinical Practice Consensus Guidelines

Updated ISPAD guidelines on pathophysiology, diagnosis, clinical course and management of Cystic-fibrosis Related Diabetes. These talk about the role of glucose tolerance tests, hemoglobin A1c, continuous…

Hgb A1c Measurement for the Diagnosis of Type 2 Diabetes in Children (Int. J of Ped. Endocrinology 2012)

Laboratory measurements of hemoglobin A1c above 6.5% were approved as an additional diagnostic criteria for diabetes mellitus by the American Diabetes Association in 2010. Several pediatric…

TODAY: A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes

A comparison of the efficacy of three treatment regimens to achieve durable glycemic control in children and adolescents with recent-onset type 2 diabetes.

Hyperglycemic Hyperosmolar Syndrome in Children: Pathophysiological Considerations and Suggested Guidelines for Treatment (J of Pediatrics 2011)

HHS pathophysiology, treatment and complications in children.

Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes. PES D&T Committee Position statement. (Pediatrics 2006)

This review summarizes efficacy and safety of continuous subcutaneous insulin infusion in children ≤6 years of age, present potential pros and cons of using insulin pumps…

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Prospective study conducted by the Diabetes Prevention Program Research Group, looking at reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.